170 related articles for article (PubMed ID: 32411653)
1. Platinum(II) Terpyridine Anticancer Complexes Possessing Multiple Mode of DNA Interaction and EGFR Inhibiting Activity.
Li C; Xu F; Zhao Y; Zheng W; Zeng W; Luo Q; Wang Z; Wu K; Du J; Wang F
Front Chem; 2020; 8():210. PubMed ID: 32411653
[TBL] [Abstract][Full Text] [Related]
2. Ruthenium(II) polypyridyl complexes with visible light-enhanced anticancer activity and multimodal cell imaging.
Kang Y; Zhao Y; Wei Y; Zhang Y; Wang Z; Luo Q; Du J; Wang F
Dalton Trans; 2023 Sep; 52(35):12478-12489. PubMed ID: 37602756
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines.
Du J; Kang Y; Zhao Y; Zheng W; Zhang Y; Lin Y; Wang Z; Wang Y; Luo Q; Wu K; Wang F
Inorg Chem; 2016 May; 55(9):4595-605. PubMed ID: 27093574
[TBL] [Abstract][Full Text] [Related]
4. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F
Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875
[TBL] [Abstract][Full Text] [Related]
5. A platinum complex that binds non-covalently to DNA and induces cell death via a different mechanism than cisplatin.
Suntharalingam K; Mendoza O; Duarte AA; Mann DJ; Vilar R
Metallomics; 2013 May; 5(5):514-23. PubMed ID: 23487034
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(ii) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(ii) complexes in relation to the complex structure.
Konovalov B; Živković MD; Milovanović JZ; Djordjević DB; Arsenijević AN; Vasić IR; Janjić GV; Franich A; Manojlović D; Skrivanj S; Milovanović MZ; Djuran MI; Rajković S
Dalton Trans; 2018 Oct; 47(42):15091-15102. PubMed ID: 30303498
[TBL] [Abstract][Full Text] [Related]
7. Human thioredoxin reductase is efficiently inhibited by (2,2':6',2' '-terpyridine)platinum(II) complexes. Possible implications for a novel antitumor strategy.
Becker K; Herold-Mende C; Park JJ; Lowe G; Schirmer RH
J Med Chem; 2001 Aug; 44(17):2784-92. PubMed ID: 11495589
[TBL] [Abstract][Full Text] [Related]
8. EGFR-targeting peptide-coupled platinum(IV) complexes.
Mayr J; Hager S; Koblmüller B; Klose MHM; Holste K; Fischer B; Pelivan K; Berger W; Heffeter P; Kowol CR; Keppler BK
J Biol Inorg Chem; 2017 Jun; 22(4):591-603. PubMed ID: 28405842
[TBL] [Abstract][Full Text] [Related]
9. Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders.
Gama S; Rodrigues I; Mendes F; Santos IC; Gabano E; Klejevskaja B; Gonzalez-Garcia J; Ravera M; Vilar R; Paulo A
J Inorg Biochem; 2016 Jul; 160():275-86. PubMed ID: 27267415
[TBL] [Abstract][Full Text] [Related]
10. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
[TBL] [Abstract][Full Text] [Related]
11. Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1.
Lo YC; Ko TP; Su WC; Su TL; Wang AH
J Inorg Biochem; 2009 Jul; 103(7):1082-92. PubMed ID: 19525010
[TBL] [Abstract][Full Text] [Related]
12. Three Pt-Pt Complexes with Donor-acceptor Feature: Anticancer Activity, DNA Binding Studies and Molecular Docking Simulation.
Ashoo P; Yousefi R; Nabavizadeh SM; Aseman MD; Paziresh S; Ghasemi A; Saboury AA
Anticancer Agents Med Chem; 2019; 19(14):1762-1774. PubMed ID: 31267879
[TBL] [Abstract][Full Text] [Related]
13. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
[TBL] [Abstract][Full Text] [Related]
14. Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity.
Ji L; Zheng W; Lin Y; Wang X; Lü S; Hao X; Luo Q; Li X; Yang L; Wang F
Eur J Med Chem; 2014 Apr; 77():110-20. PubMed ID: 24631730
[TBL] [Abstract][Full Text] [Related]
15. Cationic Pd(II)/Pt(II) 5,5-diethylbarbiturate complexes with bis(2-pyridylmethyl)amine and terpyridine: Synthesis, structures,DNA/BSA interactions, intracellular distribution, cytotoxic activity and induction of apoptosis.
Icsel C; Yilmaz VT; Kaya Y; Durmus S; Sarimahmut M; Buyukgungor O; Ulukaya E
J Inorg Biochem; 2015 Nov; 152():38-52. PubMed ID: 26339715
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a dual-targeting organometallic ruthenium complex with high activity inducing early stage apoptosis of cancer cells.
Du J; Zhang E; Zhao Y; Zheng W; Zhang Y; Lin Y; Wang Z; Luo Q; Wu K; Wang F
Metallomics; 2015 Dec; 7(12):1573-83. PubMed ID: 26446567
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel gefitinib-based derivatives and their anticancer activity.
Sharma MJ; Kumar MS; Murahari M; Mayur YC
Arch Pharm (Weinheim); 2019 May; 352(5):e1800381. PubMed ID: 31012144
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antitumor activities of three novel binuclear platinum(II) complexes with 4'-substituted-2,2':6',2″-terpyridine ligands.
Qin QP; Wang ZF; Wang SL; Luo DM; Zou BQ; Yao PF; Tan MX; Liang H
Eur J Med Chem; 2019 May; 170():195-202. PubMed ID: 30897397
[TBL] [Abstract][Full Text] [Related]
20. 5-Nitro-Thiophene-Thiosemicarbazone Derivatives Present Antitumor Activity Mediated by Apoptosis and DNA Intercalation.
Roque Marques KM; do Desterro MR; de Arruda SM; de Araújo Neto LN; do Carmo Alves de Lima M; de Almeida SMV; da Silva ECD; de Aquino TM; da Silva-Júnior EF; de Araújo-Júnior JX; de M Silva M; de A Dantas MD; Santos JCC; Figueiredo IM; Bazin MA; Marchand P; da Silva TG; Mendonça Junior FJB
Curr Top Med Chem; 2019; 19(13):1075-1091. PubMed ID: 31223089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
